Wave Life Sciences
61 hedge funds and large institutions have $243M invested in Wave Life Sciences in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 9 closing their positions.
2,456% more call options, than puts
Call options by funds: $230K | Put options by funds: $9K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
10% more capital invested
Capital invested by funds: $220M → $243M (+$22.5M)
2% more funds holding
Funds holding: 60 → 61 (+1)
0.69% less ownership
Funds ownership: 78.16% → 77.47% (-0.69%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.42M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.88M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$1.61M |
| 4 |
Walleye Capital
New York
|
+$1.33M |
| 5 |
Goldman Sachs
New York
|
+$839K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.46M |
| 2 |
D.E. Shaw & Co
New York
|
-$2.1M |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$1.78M |
| 4 |
Millennium Management
New York
|
-$1.71M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.21M |
WVE Hedge Fund Activity: Q3 2022 in Review
61 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2022, worth a combined $243M — up 10% from $220M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new WVE positions and 9 closed out — a net gain of 1 holder — while 19 added to existing stakes and 16 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $3.42M. The largest seller was Adage Capital Partners, cutting an estimated $4.46M.
- 61 institutional investors held Wave Life Sciences (WVE) as of Q3 2022, up from 60 in Q2 2022.
- Funds reported $243M of Wave Life Sciences stock for Q3 2022, up 10% quarter-over-quarter.
- 10 funds opened new Wave Life Sciences positions in Q3 2022 and 9 closed out, a net change of +1 holder.
- The largest Wave Life Sciences buyer in Q3 2022 was Point72 Asset Management, an estimated $3.42M added.
- The largest Wave Life Sciences seller in Q3 2022 was Adage Capital Partners, an estimated $4.46M sold.
Based on aggregated 13F filings for Q3 2022.